Read more Explore options if your insurance stops covering GLP-1 meds
Currently available GLP-1 receptor agonists in the United States include exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
[10] Patients on a microdose of 0.05 mg once daily lost about 6 lbs over 26 weeks
You accidentally leave your semaglutide out overnight
We wanted to better understand what life on GLP-1s for weight loss really looks like: What can you expect when you first start taking the drug